Baxter Gets FDA Warning Letter Over Mold, Hair

Law360, New York (June 12, 2013, 7:00 PM EDT) -- Baxter Healthcare Corp. failed to investigate extensive mold near a pharmaceutical fill line and produced drug products tainted with hair, skin and other particles, the U.S. Food and Drug Administration said in a warning letter released Tuesday that echoed previous criticisms of the company.

The letter, which was sent May 31, accuses Illinois-based Baxter of turning a blind eye to contamination at its Marion, N.C., plant, where inspectors said they found air filters with “discolored areas, chipping paint, multicolored coalescing droplets and clumps of dark material...
To view the full article, register now.